The MedAffairs Leaders Forum is widely-recognized as the place where medical affairs professionals obtain actionable insights to transform medical affairs into a function that truly adds-value to healthcare systems and especially patients. Attendees will network with experts and thought-leaders to understand issues like:

  1. Patient-centricity: How to change culture, add-value and put the patient at the center of the organization in practice
  2. Digital: Realizing the potential and the power that technology provides, whether it’s tapping unique external data sources, understanding patient needs through online patient communities, or enhancing R&D intelligence through Artificial Intelligence or Big Data.
  3. Communications: Leveraging both classical communications channels, such as publications or symposia, as well as social media, to ethically communicate evidence-based messages with key stakeholders.
  4. Real-world evidence and IITs: Working with External Experts, academic networks, registries or payers to achieve a more granular-level understanding of how a therapy works in the real world.
  5. Strategy and capabilities: Transforming medical affairs into a function that facilities the entire organization to be focused on satisfying stakeholder needs and enhancing the quality of evidence to truly add-value.
Request agenda here for complete speaker list

PHARMA INDUSTRY

Vice President, Medical Affairs
Norgine

Head of Medical Affairs-Primary Care & Women's Health
Merck

Global Field Based Medical Excellence Head
Sanofi Genzyme

Vice President, North America Medical Affairs Drug Safety and Pharmacovigilance
Leadiant Biosciences

Cardiovascular Metabolic Lead, US Medical Director
Pfizer

Global Brand Medical Director, RCC & Sarcoma
Novartis

Director, Scientific Communications and Publications Established Products and Emerging Markets
Sanofi

CEO and Cofounder
E=MC2, no limits...

Strategic Medical Communications Lead
Merz

Global/US Field Medical Data Analytics Lead, Diabetes and Cardiovascular
Sanofi

Medical Director - International and Partnerships
Norgine

Vice President, Medical Affairs, Medical Director
Revision Optics

Senior Director Medical Affairs, Strategy, Operations, and Alliance Management
Takeda

CEO, Executive Coach & Psychologist
Pinnacle Wellbeing 247
 

MEDTECH INDUSTRY

CEO
MMJ Labs Pain Relief

SVP Head Clinical Development
BTG International, UK

Vice President, Head of Medical Affairs
Haemonetics

Senior Director, Global Medical Science Liaison
Royal Philips

Vice President Clinical and Medical Affairs
Teleflex Medical

Senior Director, Global Scientific Affairs
Luminex Corporation, USA

Director of Medical Affairs Operations
BTG

Head of Medical and Scientific Affairs
Roche Diagnostics 

 

PATIENTS AND ONLINE COMMUNITIES

Vice President, Product
Inspire (Online Patient Communities)

Founder and CEO
Lyfebulb

Founder and CEO
PatientLink Enterprises

President, Society for Participatory Medicine
Founder, Health Collaboratory
Executive Director, Cancer 101

Board of directors, Neurofibromatosis Northeast
Patient Representative, Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration

ACADEMIC RESEARCHERS

Professor of Medicine Director, GI Oncology Program & Leader, Experimental Therapeutics
Tufts University

Assistant Director, Clinical Data Management and Quality Controls, Auditing and Training
University of Kansas Medical Center

General Health Scientist, Senior Scientific Program Manager
FDA

Director Of Research
Tufts Center for the Study of Drug Development
Tufts University School of Medicine, USA

PAYERS

Senior Medical Director
Blue Cross Blue Shield of North Carolina

 

TECHNOLOGY COMPANIES

Senior Vice President and Chief Medical Officer
Qualcomm Life

CEO and Co-Founder
Buoy Health

Request agenda here for complete speaker list

Pictures from recent MedAffairs Leaders Forum. Imagine being there...

This session focuses on Strategic Medical Affairs Management, specifically how Medical Affairs as a function can be at the forefront of offering added-value to key external and internal stakeholders. Furthermore, how Medical Affairs can become a strategic enabler for the entire organization by facilitating strong evidence and engagement that creates clear ROI. The issue of patient-centricity in practice will also be examined with perspectives, approaches and case studies presented. This will provide participants with actionable insights to help implement more patient-beneficial and focused activities that put the patient at the center of everything we do.

Speaker List - Day 1

Vice President, Medical Affairs
Norgine

CEO, Executive Coach & Psychologist
Pinnacle Wellbeing 247

Head of Medical Affairs-Primary Care & Women's Health
Merck

Global Field Based Medical Excellence Head
Sanofi Genzyme

Vice President, North America Medical Affairs Drug Safety and Pharmacovigilance
Leadiant Biosciences

Cardiovascular Metabolic Lead, US Medical Director
Pfizer

CEO
MMJ Labs Pain Relief

Senior Vice President and Chief Medical Officer
Qualcomm Life

Senior Medical Director
Blue Cross Blue Shield of North Carolina

Vice President, Product
Inspire (Online Patient Communities)

Board of directors, Neurofibromatosis Northeast
Patient Representative, Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration

Founder and CEO
Lyfebulb

Founder and CEO
PatientLink Enterprises

Medical Affairs and MSL teams are increasingly looking to implement next generation medical communication practices. They need to offer essential evidence-based information to stakeholders on demand, through a variety of classical, yet also increasingly digital channels. This stream will focus on three key aspects of medical communication. Firstly, issues such as:

Protocol writing for internal late-phase studies and research initiatives; working with External Experts (KOLs) to enhance publications, abstracts & posters and receiving proposals for investigator-initiated studies. The second section of this day will focus on medical/scientific communications, including the review process, compliance issues, ensuring the claims made by marketing colleagues are justified and appropriately communicated and also effectively localized from global-level to country-level market requirements. The third area is looking at how the MSL can best be at the forefront of communicating the value message and engaging KOLs and other stakeholders.

Speaker List - Day 2 - Stream 1

Global Brand Medical Director, RCC & Sarcoma
Novartis

Director, Scientific Communications and Publications Established Products and Emerging Markets
Sanofi

CEO and Cofounder
E=MC2, no limits...

CEO and Co-Founder
Buoy Health

Strategic Medical Communications Lead
Merz

Global/US Field Medical Data Analytics Lead, Diabetes and Cardiovascular
Sanofi

President, Society for Participatory Medicine
Founder, Health Collaboratory
Executive Director, Cancer 101

Medical Director - International and Partnerships
Norgine

Generating real-world evidence via observational studies, the use of patient registries or Investigator Initiated Trials (IITs) is one of the fastest growing areas of pharmaceutical R&D. Such post-marketing studies are becoming increasingly important as regulatory agencies demand more long-term data which demonstrates effectiveness from a clinical perspective, yet payers are also demanding evidence of economic value. The Medical Affairs unit plays a decisive role in generating this vital evidence and this stream will present solutions to the challenges companies face in generating high-quality evidence which will enable the communication of a compelling “value” argument to all external stakeholders.

Speaker List - Day 2 - Stream 2

Director Of Research
Tufts Center for the Study of Drug Development
Tufts University School of Medicine, USA

SVP Head Clinical Development
BTG International, UK

Vice President, North America Medical Affairs Drug Safety and Pharmacovigilance
Leadiant Biosciences

Vice President, Medical Affairs, Medical Director
Revision Optics

Founder and CEO
PatientLink Enterprises

Senior Director Medical Affairs, Strategy, Operations, and Alliance Management
Takeda

Professor of Medicine Director, GI Oncology Program & Leader, Experimental Therapeutics
Tufts University

Assistant Director, Clinical Data Management and Quality Controls, Auditing and Training
University of Kansas Medical Center

This session focuses on the fast-evolving role of Medical Affairs specifically for MedTech companies and the increasingly important need for this function which facilitates overall corporate performance. The different business model of MedTech vs Pharma, necessitates an adjustment in the way KOLs, external experts & patients are engaged with and communicated to. This highly popular, 1-day stream is back and with new speakers, will enable the MedTech community to get the most out of their Medical Affairs teams and develop a more patient-centric business model.

Speaker List - Day 3Vice President, Head of Medical Affairs Haemonetics

Vice President, Head of Medical Affairs
Haemonetics

Senior Director, Global Medical Science Liaison
Royal Philips

Head of Medical and Scientific Affairs
Roche Diagnostics 

Director of Medical Affairs Operations
BTG

Vice President Clinical and Medical Affairs
Teleflex Medical

Senior Director, Global Scientific Affairs
Luminex Corporation, USA

General Health Scientist, Senior Scientific Program Manager
FDA

The industry-leading ‘Charisma Masterclass for Medical Affairs Executives’ is the top personal effectiveness training program. It helps senior executives to uncover and utilize their latent inner power.

The Charisma Masterclass is uniquely tailored for entrepreneurs, business leaders and high potential professionals. Participants will learn to fast track ability to create the perfect first impression and to optimize each and every interaction. Register now and learn how to influence, persuade, and inspire.

Workshop Leader
Richard Reid
CEO, Executive Coach & Psychologist
Pinnacle Wellbeing 247

This event will provide all delegates the chance to meet one another through our many networking opportunities. With pre-event, mid-morning and mid-afternoon breaks as a standard, this event will also feature a complimentary networking dinner for all participants.

This evening will allow you to meet with our expert speaker panel who represent many stakeholder groups in a less formal setting. Our networking lunches will also allow you plenty of time to meet with your peers and colleagues whilst you refuel through the event.

PHARMA & MEDICAL DEVICE: VPs, Directors & Managers of:
Medical Affairs, Medical Science Liaisons, Medical Education, Health Outcomes & Liaison, Medical Communications, Marketing, KOL & Stakeholder Engagement, Late Phase & Real-World Research, Investigator-Initiated Research, Field HEOR, Field Medical, Scientific Affairs, Medical Advisors and Patient-Centricity.

Event Partners

Media Partners

This event is accredited for CPD (Continuing Professional Development) status

RECEIVE DISCOUNTED FLIGHTS WHEN YOU REGISTER FOR THIS EVENT WITH

Share with Colleagues